Focus on knowledge creation

Without ideas there is nothing to manage

Nature Reviews Drug Discovery has published an article addressing the link between the ongoing IMI projects and regulatory science. The article entitled The Innovative Medicines Initiative: an engine for regulatory science highlights key outcomes of several IMI projects, together with lessons learned, now that IMI is moving to its second phase.
The article refers to several projects funded within IMI 1 –eTOX, ADVANCE and EPAD- in which Synapse participates with responsibilities in project management, sustainability and dissemination.
The importance to translate scientific results into the regulatory framework are highlighted in this article, together with a call to projects to start contacts with the regulatory bodies as early as possible in order to align regulatory requirements as much as possible.